- About Us
- HCP Resources
- My Account
Welcome to PreCardix® Professional Resources. This section provides important information for health care providers on prescribing PreCardix® to patients. Content on this page has been reviewed internally by our Medical Advisory Board. If you have any additional questions about PreCardix®, please contact us directly at firstname.lastname@example.org.
PreCardix® is the result of over a decade research and development dedicated to finding an effective, sustainable and proven natural product to support blood pressure health.
Two clinical studies, Mare-study (preliminary clinical trial) and Marealis 13TBHM (peer-reviewed, double-blind, placebo-controlled, multicentre clinical trial), were conducted on the bioactive marine peptides (RSPC) in PreCardix® between 2012 and 2015 on over two hundred and twenty male and female participants aged 30 – 75.
Clinical research found that the unique bioactive marine peptides derived from hydrolyzed shrimp shells (Pandalus Borealis) found in PreCardix® have an ACE inhibiting mechanism of action. The use of bioactive marine peptides in clinical trials resulted in a statistically significant effect on blood pressure health in over 89% of participants within eight weeks or less.
Highlights of the Marealis 13TBHM study:
For more information on PreCardix® clinical indications, safety and effectiveness, please review the resources below, including clinical research, product monographs, and FAQs.